Cathepsin-D expression in breast lesion: An immunohistochemical study

Romanian Journal of Morphology and Embryology

Volumn 50, Issue 1, 2008, Pages 31-39

  Brujan, Iulia ^a   Margaritescu C ^a   Simionescu, Cristiana ^a   Pirici, D ^a   Fronie, A ^a   Foarfǎ, Camelia ^a   Stepan, A ^b   Vrabete, Maria ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b No 1 Emergency County Hospital   (Romania)

Author keywords

Breast; Carcinoma; Cathepsin D; Immunohistochemistry

Indexed keywords

EID: 70249087321     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BRAY F., SANKILA R., FERLAY J., PARKIN D. M., Estimates of cancer and mortality in Europe in 1995, Eur J Cancer, 2002, 38(1):99-166.
2. METTLIN C., Global breast cancer mortality statistics, CA Cancer J Clin, 1999, 49(3):138-144.
3. HARRIS L., FRITSCHE H., MENNEL R., NORTON L., RAVDIN P., TAUBE S., SOMERFIELD M. R., HAYES D. F., BAST R. C. JR.; AMERICAN SOCIETY OF CLINICAL ONCOLOGY, American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer, J Clin Oncol, 2007, 25(33):5287-5312.
4. DEAN R. T., Direct evidence of importance of lysosomes in degradation of intracellular proteins, Nature, 1975, 257(5525):414-416.
5. IKEGUCHI M., FUKUDA K., OKA S., YAMAGUCHI K., HISAMITSU K., TSUJITANI S., SAKATANI T., UEDA T., KAIBARA N., Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma, Oncology, 2001, 61(1):71-78.
6. THEODOROPOULOS G. E., PANOUSSOPOULOS D., LAZARIS A. C., GOLEMATIS B. C., Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma, J Surg Oncol, 1997, 65(4):242-248.
7. TÊTU B., BRISSON J., LAPOINTE H., WANG C. S., BERNARD P., BLANCHETTE C., Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases, Breast Cancer Res Treat, 1999, 55(2):137-147.
8. BARRETT A. J., Cathepsin D. Purification of isoenzymes from human and chicken liver, Biochem J, 1970,117(3):601-607.
9. VAN NOORT J. M., VAN DER DRIFT A. C., The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes, J Biol Chem, 1989, 264(24):14159-14164.
10. MIZUOCHI T., YEE S. T., KASAI M., KAKIUCHI T., MUNO D., KOMINAMI E., Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain, Immunol Lett, 1994, 43(3):189-193.
11. SAFTIG P., HETMAN M., SCHMAHL W., WEBER K., HEINE L., MOSSMANN H., KÖSTER A., HESS B., EVERS M., VON FIGURA K. et al., Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells, EMBO J, 1995, 14(15):3599-3608.
12. AUTHIER F., MORT J. S., BELL A. W., POSNER B. I., BERGERON J. J., Proteolysis of glucagon within hepatic endosomes by membrane-associated cathepsins B and D, J Biol Chem, 1995, 270(26):15798-15807.
13. KRIEGER T. J., HOOK V. Y., Purification and characterization of a cathepsin D protease from bovine chromaffin granules, Biochemistry, 1992, 31(17):4223-4231.
14. DIMENT S., MARTIN K. J., STAHL P. D., Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins, J Biol Chem, 1989, 264(23):13403-13406.
15. CAVAILLÉS V., GARCIA M., ROCHEFORT H., Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells, Mol Endocrinol, 1989, 3(3):552-558.
16. ESCOT C., ZHAO Y., PUECH C., ROCHEFORT H., Cellular localization by in situ hybridization of cathepsin D, stromelysin 3 and urokinase plasminogen activator RNAs in breast cancer, Breast Cancer Res Treat, 1996, 38(2):217-226.
17. ROCHEFORT H., CAVAILLÉS V., AUGEREAU P., CAPONY F., MAUDELONDE T., TOUITOU I., GARCIA M., Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer, J Steroid Biochem, 1989, 34(1-6):177-182.
18. ROGER P., MONTCOURRIER P., MAUDELONDE T., BROUILLET J. P., PAGES A., LAFFARGUE F., ROCHEFORT H., Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay, Hum Pathol, 1994, 25(9):868-871.
19. CAPONY F., ROUGEOT C., MONTCOURRIER P., CAVAILLES V., SALAZAR G., ROCHEFORT H., Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells, Cancer Res, 1989, 49(14):3904-3909.
20. SCHULTZ D. C., BAZEL S., WRIGHT L. M., TUCKER S., LANGE M. K., TACHOVSKY T., LONGO S., NIEDBALA S., ALHADEFF J. A., Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls, Cancer Res, 1994, 54(1):48-54.
21. STOMPER P. C., WINSTON J. S., HERMAN S., KLIPPENSTEIN D. L., BLUMENSON L. E., Cathepsin D and dynamic magnetic resonance imaging gadolinium enhancement in malignant and benign breast lesions, Clin Cancer Res, 1997, 3(4):559-563.
22. ZHENG W. Q., LOOI L. M., CHEAH P. L., A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma, Pathology, 1999, 31(3):247-251.
23. WOLF M., CLARK-LEWIS I., BURI C., LANGEN H., LIS M., MAZZUCCHELLI L., Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer, Am J Pathol, 2003, 162(4):1183-1190.
24. FERNANDEZ-AGUILAR S., NOËL J. C., Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast, APMIS, 2008, 116(1):33-40.
25. FOEKENS J. A., LOOK M. P., BOLT-DE VRIES J., MEIJER-VAN GELDER M. E., VAN PUTTEN W. L. J., KLIJN J. G. M., Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients, Br J Cancer, 1999, 79(2):300-307.
26. RODRÍGUEZ J., VÁZQUEZ J., CORTE M. D., LAMELAS M., BONGERA M., CORTE M. G., ALVAREZ A., ALLENDE M., GONZALEZ L., SÁNCHEZ M., VIJANDE M., GARCIA MUÑIZ J., VIZOSO F., Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer, Int J Biol Markers, 2005, 20(2):103-111.
27. AZIZ S., PERVEZ S., KHAN S., KAYANI N., RAHBAR M., Immunohistochemical cathepsin-D expression in breast cancer: correlation with established pathological parameters and survival, Pathol Res Pract, 2001,197(8):551-557.
28. KUTE T. E., GRØNDAHL-HANSEN J., SHAO S. M., LONG R., RUSSEL G., BRÜNNER N., Low cathepsin D and low plasminogen activator type I inhibitor in tumor cytosols defines a group of node-negative breast cancer patients with low risk of recurrence, Breast Cancer Res Treat, 1998, 47(1):9-16.
29. FERNÖ M., BALDETORP B., BORG A., BROUILLET J. P., OLSSON H., ROCHEFORT H., SELLBERG G., SIGURDSSON H., KILLANDER D., Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. Sweden Breast Cancer Group, Eur J Cancer, 1994, 30A(14):2042-2048.